Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastrointestinal Neoplasms × Reverse Transcriptase Polymerase Chain Reaction × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Rectal Neoplasms 2 Prostatic Neoplasms 2 Lung Neoplasms 2 Leukemia 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Multiple Myeloma 1 Liposarcoma 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioma, Subependymal 1 Glioma 1 Glioblastoma 1 Esophageal Squamous Cell Carcinoma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Cardiotoxicity 1

Interventions

Leucovorin 4 Irinotecan 4 Fluorouracil 4 Oxaliplatin 3 Bevacizumab 3 cobimetinib 2 Standard of Care 2 Specimen Handling 2 Panitumumab 2 Magnetic Resonance Spectroscopy 2 Ketamine 2 Hydroxychloroquine 2 Cisplatin 2 Capecitabine 2 ulixertinib 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tivozanib 1 sodium thiosulfate 1 rucaparib 1 romiplostim 1 rilotumumab 1 regorafenib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 osimertinib 1 napabucasin 1 lanreotide 1 irinotecan sucrosofate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡